
Middle East and Africa Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tra
Description
Middle East and Africa Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
The Middle East and Africa carbapenem-based antibiotics market is expected to reach US$ 297.20 million by 2028 from US$ 237.42 million in 2021; it is estimated to grow at a CAGR of 3.3% from 2021-2028.
The market's growth is attributed to factors such as the rising prevalence of bacterial infections and increasing private and public partnerships of leading pharmaceutical players. However, the tedious and expensive process of developing antibiotics is expected to restrain the market's growth during the forecast period.
Technological developments in the pharmaceutical industry led to drastic evolution and better treatment. The pharmaceutical industry has incorporated intelligent technologies such as deep learning, artificial intelligence (AI), and machine learning to develop new antibiotics. Researchers are working to establish tools and platforms for identifying new antibiotics. It is expected that the novel technologies in new antibiotic discoveries are supposed to change the overall antibiotics market. However, developing antibiotics for gram-negative bacteria is challenging, as various drugs are still developing.
The major challenge for the development of antibiotics is the limited permeability of molecules across the bacterial envelope. However, gram-negative bacteria have nutrient-specific protein channels (porins) that restrict the permeability of non-essential molecules, including antibiotics. Permeability has allowed researchers to develop a new platform called computational antibiotic screening (CLASP), which helps identify potential drug molecules through porins.
CLASP has the advantage of coarse grain (CG) resolution, advanced sampling techniques, and a parallel computing environment that maximizes its performance. It provides complete thermodynamic and kinetic results of a potential drug molecule under study in a few hours. It helps in understanding or identifying small molecule libraries that yield structure-property relationships to discover antibiotics with high permeability. Thus, it is expected that CLASP will accelerate the new antibiotic drug for gram-negative bacterial infections, thus further leading to significant market growth.
Also, generic versions are popular due to their availability and affordability. In addition, the expiry of patented carbapenem-based antibiotics has widen-up opportunities for generic drug manufacturers to enter the market with their cost-efficient drugs. As a result, companies are accelerating generic drug production and driving the Middle East carbapenem-based antibiotics market.
Middle East & Africa Carbapenem-Based Antibiotics Market Revenue and Forecast to 2028 (US$ million)
MIDDLE EAST & AFRICA CARBAPENEM-BASED ANTIBIOTICS MARKET SEGMENTATION
By Type
Meropenem Imipenem Doripenem Tebipenem Others By Indication
Bacterial Meningitis Acute Pelvic Infections Respiratory Tract Infections Intra-Abdominal Infections Urinary Tract Infections Others By Distribution Channel
Hospital Pharmacies Retail Pharmacies Online Pharmacies By Country
Saudi Arabia South Africa UAE Rest of Middle East & Africa Company Profiles
ACS Dobfar S.p.A Gland Pharma Limited Merck & Co., Inc. Savior Lifetec Pfizer Inc. Spero Therapeutics
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa carbapenem-based antibiotics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa carbapenem-based antibiotics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The Middle East and Africa carbapenem-based antibiotics market is expected to reach US$ 297.20 million by 2028 from US$ 237.42 million in 2021; it is estimated to grow at a CAGR of 3.3% from 2021-2028.
The market's growth is attributed to factors such as the rising prevalence of bacterial infections and increasing private and public partnerships of leading pharmaceutical players. However, the tedious and expensive process of developing antibiotics is expected to restrain the market's growth during the forecast period.
Technological developments in the pharmaceutical industry led to drastic evolution and better treatment. The pharmaceutical industry has incorporated intelligent technologies such as deep learning, artificial intelligence (AI), and machine learning to develop new antibiotics. Researchers are working to establish tools and platforms for identifying new antibiotics. It is expected that the novel technologies in new antibiotic discoveries are supposed to change the overall antibiotics market. However, developing antibiotics for gram-negative bacteria is challenging, as various drugs are still developing.
The major challenge for the development of antibiotics is the limited permeability of molecules across the bacterial envelope. However, gram-negative bacteria have nutrient-specific protein channels (porins) that restrict the permeability of non-essential molecules, including antibiotics. Permeability has allowed researchers to develop a new platform called computational antibiotic screening (CLASP), which helps identify potential drug molecules through porins.
CLASP has the advantage of coarse grain (CG) resolution, advanced sampling techniques, and a parallel computing environment that maximizes its performance. It provides complete thermodynamic and kinetic results of a potential drug molecule under study in a few hours. It helps in understanding or identifying small molecule libraries that yield structure-property relationships to discover antibiotics with high permeability. Thus, it is expected that CLASP will accelerate the new antibiotic drug for gram-negative bacterial infections, thus further leading to significant market growth.
Also, generic versions are popular due to their availability and affordability. In addition, the expiry of patented carbapenem-based antibiotics has widen-up opportunities for generic drug manufacturers to enter the market with their cost-efficient drugs. As a result, companies are accelerating generic drug production and driving the Middle East carbapenem-based antibiotics market.
Middle East & Africa Carbapenem-Based Antibiotics Market Revenue and Forecast to 2028 (US$ million)
MIDDLE EAST & AFRICA CARBAPENEM-BASED ANTIBIOTICS MARKET SEGMENTATION
By Type
Meropenem Imipenem Doripenem Tebipenem Others By Indication
Bacterial Meningitis Acute Pelvic Infections Respiratory Tract Infections Intra-Abdominal Infections Urinary Tract Infections Others By Distribution Channel
Hospital Pharmacies Retail Pharmacies Online Pharmacies By Country
Saudi Arabia South Africa UAE Rest of Middle East & Africa Company Profiles
ACS Dobfar S.p.A Gland Pharma Limited Merck & Co., Inc. Savior Lifetec Pfizer Inc. Spero Therapeutics
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa carbapenem-based antibiotics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa carbapenem-based antibiotics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
116 Pages
- 1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Middle East and Africa Carbapenem-based Antibiotics Market - By Type
- 1.3.2 Middle East and Africa Carbapenem-based Antibiotics Market - By Indication
- 1.3.3 Middle East and Africa Carbapenem-based Antibiotics Market - By Distribution Channel
- 1.3.4 Middle East and Africa Carbapenem-based Antibiotics Market - By Country
- 2. Carbapenem-based Antibiotics Market - Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. Middle East and Africa Carbapenem-based Antibiotics Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 Middle East and Africa- PEST Analysis
- 4.3 Expert Opinions
- 5. Carbapenem-based Antibiotics Market - Key Market Dynamics
- 5.1 Drivers
- 5.1.1 Rising Prevalence of Gram-Negative Bacterial Infections
- 5.1.2 Increasing Production of Generic Drugs
- 5.2 Market Restraints
- 5.2.1 Tedious and Expensive Process of Antibiotic Development
- 5.3 Market Opportunities
- 5.3.1 Private and Public Partnerships
- 5.4 Future Trends
- 5.4.1 Strategic Advancement for New Antibiotic Identification
- 5.5 Impact Analysis
- 6. Carbapenem-based Antibiotics Market - Middle East and Africa Analysis
- 6.1 Middle East and Africa Carbapenem-based Antibiotics Market Revenue Forecast and Analysis
- 7. Carbapenem-based Antibiotics Market Analysis - By Type
- 7.1 Overview
- 7.2 Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)
- 7.3 Meropenem
- 7.3.1 Overview
- 7.3.2 Meropenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Doripenem
- 7.4.1 Overview
- 7.4.2 Doripenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Imipenem
- 7.5.1 Overview
- 7.5.2 Imipenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 Tebipenem
- 7.6.1 Overview
- 7.6.2 Tebipenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 8. Carbapenem-based Antibiotics Market - By Indication
- 8.1 Overview
- 8.2 Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)
- 8.3 Bacterial Meningitis
- 8.3.1 Overview
- 8.3.2 Bacterial Meningitis: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Acute Pelvic Infections
- 8.4.1 Overview
- 8.4.2 Acute Pelvic Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Respiratory Tract Infections
- 8.5.1 Overview
- 8.5.2 Respiratory Tract Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 8.6 Intra-abdominal Infections
- 8.6.1 Overview
- 8.6.2 Intra-abdominal Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 8.7 Urinary Tract Infections
- 8.7.1 Overview
- 8.7.2 Urinary Tract Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 9. Carbapenem-based Antibiotics Market - By Distribution Channel
- 9.1 Overview
- 9.2 Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)
- 9.3 Retail Pharmacies
- 9.3.1 Overview
- 9.3.2 Retail Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Online Pharmacies
- 9.4.1 Overview
- 9.4.2 Online Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Hospital Pharmacies
- 9.5.1 Overview
- 9.5.2 Hospital Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- 10. Carbapenem-based Antibiotics Market -Country Analysis
- 10.1 Middle East and Africa: Carbapenem-based Antibiotics Market
- 10.1.1 Overview
- 10.1.2 Middle East and Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- 10.1.3 Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
- 10.1.4 Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ Million)
- 10.1.5 Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ Million)
- 10.1.6 Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
- 10.1.6.1 UAE: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- 10.1.6.1.1 UAE: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- 10.1.6.1.2 UAE: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
- 10.1.6.1.3 UAE: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
- 10.1.6.1.4 UAE: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
- 10.1.6.2 Saudi Arabia: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- 10.1.6.2.1 Saudi Arabia: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- 10.1.6.2.2 Saudi Arabia: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
- 10.1.6.2.3 Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
- 10.1.6.2.4 Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
- 10.1.6.3 South Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- 10.1.6.3.1 South Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- 10.1.6.3.2 South Africa: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
- 10.1.6.3.3 South Africa: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
- 10.1.6.3.4 South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
- 10.1.6.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- 10.1.6.4.1 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- 10.1.6.4.2 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
- 10.1.6.4.3 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
- 10.1.6.4.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
- 11. Carbapenem-based Antibiotics Market-Industry Landscape
- 11.1 Overview
- 11.2 Organic Developments
- 11.2.1 Overview
- 11.3 Inorganic Developments
- 11.3.1 Overview
- 12. COMPANY PROFILES
- 12.1 ACS Dobfar S.p.A
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Gland Pharma Limited
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Merck & Co., Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Savior Lifetec
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Pfizer Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Spero Therapeutics
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
- List of Tables
- Table 1. Middle East and Africa: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 2. Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
- Table 3. Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 4. UAE: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 5. UAE: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 6. UAE: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 7. Saudi Arabia: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 8. Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 9. Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 10. South Africa: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 11. South Africa: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 12. South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 13. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 14. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 15. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
- Table 16. Organic Developments in the Carbapenem-based Antibiotics Market
- Table 17. Inorganic Developments in the Carbapenem-based Antibiotics Market
- Table 18. Glossary of Terms, Carbapenem-based Antibiotics Market
- List of Figures
- Figure 1. Carbapenem-based Antibiotics Market Segmentation
- Figure 2. Carbapenem-based Antibiotics Segmentation, By Country
- Figure 3. Middle East and Africa Carbapenem-based Antibiotics Market Overview
- Figure 4. The Others Segment Held Largest Share of Type Segment in Carbapenem-based Antibiotics Market
- Figure 5. Middle East and Africa Carbapenem-based Antibiotics Market- Leading Country Markets (US$ Million)
- Figure 6. Middle East and Africa PEST Analysis
- Figure 7. Carbapenem-based Antibiotics Market Impact Analysis of Driver and Restraints
- Figure 8. Middle East and Africa Carbapenem-based Antibiotics Market - Revenue Forecast and Analysis - 2021- 2028
- Figure 9. Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)
- Figure 10. Meropenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 11. Doripenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 12. Imipenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Tebipenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 14. Others: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 15. Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)
- Figure 16. Bacterial Meningitis: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 17. Acute Pelvic Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 18. Respiratory Tract Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Intra-abdominal Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Urinary Tract Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 21. Others: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 22. Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)
- Figure 23. Retail Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 24. Online Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 25. Hospital Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 26. Middle East and Africa: Carbapenem-based Antibiotics Market, by Key Country - Revenue (2021) (US$ ‘Million)
- Figure 27. Middle East and Africa: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
- Figure 28. Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
- Figure 29. UAE: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- Figure 30. Saudi Arabia: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- Figure 31. South Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
- Figure 32. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.